WHO ICTRP trial
The BLESS Trial
CTIS2024-513360-25-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-513360-25-00 |
|---|---|
| Public title | The BLESS Trial |
| Scientific title | Randomised Controlled Clinical Trial Investigating the Effect of Reduced Bleomycin in Electrochemotherapy Treatment on Patients with Cutaneous Malignancies (The Bless trial) |
| Primary sponsor | Region Sjaelland |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): Yes |
| Countries | Denmark |
| Conditions | Any cancer with cutaneous malignancies;Therapeutic area: Diseases [C] - Neoplasms [C04] |
| Interventions | Product Name: , Product Code:SCP11421481, Pharmaceutical Form: , Other descriptive name: , Strength: |
| Registration date | Aug 4, 2024 |
| Target size | 55 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: